메뉴 건너뛰기




Volumn 133, Issue 2, 2012, Pages 417-426

Effect of anti-DR5 and chemotherapy on basal-like breast cancer

Author keywords

Anti DR5 antibody; Basal like breast cancer; Chemotherapy

Indexed keywords

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HLA DR5 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DR5; PACLITAXEL; UNCLASSIFIED DRUG;

EID: 84863723794     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1755-0     Document Type: Article
Times cited : (35)

References (33)
  • 1
    • 42649123535 scopus 로고    scopus 로고
    • SEER Cancer Statistics Review, 1975-2007
    • SEER Cancer Statistics Review, 1975-2007 (2010) National Cancer Institute. http://seer.cancer.gov/csr/1975-2007/
    • (2010) National Cancer Institute
  • 4
    • 1342326910 scopus 로고    scopus 로고
    • Relevance of breast cancer cell lines as models for breast tumours: An update
    • doi:10.1023/B:BREA.0000014042.54925.cc
    • Lacroix M, Leclercq G (2004) Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83(3):249-289. doi:10.1023/B:BREA.0000014042.54925.cc
    • (2004) Breast Cancer Res Treat , vol.83 , Issue.3 , pp. 249-289
    • Lacroix, M.1    Leclercq, G.2
  • 7
    • 84863720133 scopus 로고    scopus 로고
    • Definition of triple-negative breast cancer and relationship to basal-like molecular subtype
    • Liedtke C, Gonzalez-Angulo A-M, Pusztai L (2010) Definition of triple-negative breast cancer and relationship to basal-like molecular subtype. PPO Updates Prin Prac Oncol 24:1-6
    • (2010) PPO Updates Prin Prac Oncol , vol.24 , pp. 1-6
    • Liedtke, C.1    Gonzalez-Angulo, A.-M.2    Pusztai, L.3
  • 9
    • 77956170550 scopus 로고    scopus 로고
    • New insights into apoptosis signaling by Apo2L/TRAIL
    • doi: 10.1038/onc.2010.221
    • Gonzalvez F, Ashkenazi A (2010) New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29(34):4752-4765. doi: 10.1038/onc.2010.221
    • (2010) Oncogene , vol.29 , Issue.34 , pp. 4752-4765
    • Gonzalvez, F.1    Ashkenazi, A.2
  • 10
    • 45749098451 scopus 로고    scopus 로고
    • To kill a tumor cell: The potential of proapoptotic receptor agonists
    • doi:10.1172/JCI34359
    • Ashkenazi A, Herbst RS (2008) To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest 118(6):1979-1990. doi:10.1172/JCI34359
    • (2008) J Clin Invest , vol.118 , Issue.6 , pp. 1979-1990
    • Ashkenazi, A.1    Herbst, R.S.2
  • 11
    • 79952336885 scopus 로고    scopus 로고
    • Combined modality therapy with TRAIL or agonistic death receptor antibodies
    • doi:10.4161/cbt.11. 5.14671
    • Amm HM, Oliver PG, Lee CH, Li Y, Buchsbaum DJ (2011) Combined modality therapy with TRAIL or agonistic death receptor antibodies. Cancer Biol Ther 11:431-449. doi:10.4161/cbt.11. 5.14671
    • (2011) Cancer Biol Ther , vol.11 , pp. 431-449
    • Amm, H.M.1    Oliver, P.G.2    Lee, C.H.3    Li, Y.4    Buchsbaum, D.J.5
  • 12
    • 77949670310 scopus 로고    scopus 로고
    • Death receptor agonists as a targeted therapy for cancer
    • doi:10.1158/1078-0432.CCR-09-1692
    • Wiezorek J, Holland P, Graves J (2010) Death receptor agonists as a targeted therapy for cancer. Clin Cancer Res 16(6):1701-1708. doi:10.1158/1078-0432.CCR-09-1692
    • (2010) Clin Cancer Res , vol.16 , Issue.6 , pp. 1701-1708
    • Wiezorek, J.1    Holland, P.2    Graves, J.3
  • 13
    • 58149237789 scopus 로고    scopus 로고
    • TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
    • doi:10.1007/s10549-008-9924-5
    • Rahman M, Davis SR, Pumphrey JG, Bao J, Nau MM, Meltzer PS, Lipkowitz S (2009) TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Res Treat 113:217-230. doi:10.1007/s10549- 008-9924-5
    • (2009) Breast Cancer Res Treat , vol.113 , pp. 217-230
    • Rahman, M.1    Davis, S.R.2    Pumphrey, J.G.3    Bao, J.4    Nau, M.M.5    Meltzer, P.S.6    Lipkowitz, S.7
  • 14
    • 0141679399 scopus 로고    scopus 로고
    • Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model
    • Buchsbaum DJ, Zhou T, Grizzle WE, Oliver PG, Hammond CJ, Zhang S, Carpenter M, LoBuglio AF (2003) Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model. Clin Cancer Res 9:3731-3741
    • (2003) Clin Cancer Res , vol.9 , pp. 3731-3741
    • Buchsbaum, D.J.1    Zhou, T.2    Grizzle, W.E.3    Oliver, P.G.4    Hammond, C.J.5    Zhang, S.6    Carpenter, M.7    Lobuglio, A.F.8
  • 16
    • 42249113878 scopus 로고    scopus 로고
    • Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11
    • doi:10.1158/1078-0432.CCR-07-1392
    • Oliver PG, LoBuglio AF, Zinn KR, Kim H, Nan L, Zhou T, Wang W, Buchsbaum DJ (2008) Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11. Clin Cancer Res 14:2180-2189. doi:10.1158/1078-0432.CCR-07-1392
    • (2008) Clin Cancer Res , vol.14 , pp. 2180-2189
    • Oliver, P.G.1    Lobuglio, A.F.2    Zinn, K.R.3    Kim, H.4    Nan, L.5    Zhou, T.6    Wang, W.7    Buchsbaum, D.J.8
  • 17
    • 0003043542 scopus 로고
    • The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves
    • Hill AV (1910) The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 40(Suppl):4-5
    • (1910) J Physiol , vol.40 , Issue.SUPPL. , pp. 4-5
    • Hill, A.V.1
  • 18
    • 0018394195 scopus 로고
    • Simultaneous modeling of pharmacokinetics and pharmacody-namics: Application to d-tubocurarine
    • Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J (1979) Simultaneous modeling of pharmacokinetics and pharmacody-namics: application to d-tubocurarine. Clin Pharmacol Ther 25(3):358-371
    • (1979) Clin Pharmacol Ther , vol.25 , Issue.3 , pp. 358-371
    • Sheiner, L.B.1    Stanski, D.R.2    Vozeh, S.3    Miller, R.D.4    Ham, J.5
  • 19
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
    • Chou T-C, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27-55
    • (1984) Adv Enzyme Regul , vol.22 , pp. 27-55
    • Chou, T.-C.1    Talalay, P.2
  • 20
    • 2042479407 scopus 로고    scopus 로고
    • Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes
    • doi: 10.1016/j.jcis.2003.12.009
    • Zhao L, Feng SS (2004) Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes. J Colloid Interface Sci 274(1):55-68. doi: 10.1016/j.jcis.2003.12.009
    • (2004) J Colloid Interface Sci , vol.274 , Issue.1 , pp. 55-68
    • Zhao, L.1    Feng, S.S.2
  • 21
    • 0037417134 scopus 로고    scopus 로고
    • Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway
    • doi:10.1038/sj.onc.1206290
    • Ohtsuka T, Buchsbaum D, Oliver P, Makhija S, Kimberly R, Zhou T (2003) Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway. Oncogene 22:2034-2044. doi:10.1038/sj.onc.1206290
    • (2003) Oncogene , vol.22 , pp. 2034-2044
    • Ohtsuka, T.1    Buchsbaum, D.2    Oliver, P.3    Makhija, S.4    Kimberly, R.5    Zhou, T.6
  • 22
    • 33644515676 scopus 로고    scopus 로고
    • Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model
    • doi:10.1016/j.ygyno.2005.09.053
    • Straughn JM Jr, Oliver PG, Zhou T, Wang W, Alvarez RD, Grizzle WE, Buchsbaum DJ (2006) Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model. Gynecol Oncol 101:46-54. doi:10.1016/j.ygyno.2005.09.053
    • (2006) Gynecol Oncol , vol.101 , pp. 46-54
    • Straughn, Jr.J.M.1    Oliver, P.G.2    Zhou, T.3    Wang, W.4    Alvarez, R.D.5    Grizzle, W.E.6    Buchsbaum, D.J.7
  • 25
    • 43049152921 scopus 로고    scopus 로고
    • Enhancement of glioma radiation therapy and chemotherapy response with targeted antibody therapy against death receptor 5
    • doi: 10.1016/j.ijrobp.2008.02.005
    • Fiveash JB, Gillespie GY, Oliver PG, Zhou T, Belenky ML, Buchsbaum DJ (2008) Enhancement of glioma radiation therapy and chemotherapy response with targeted antibody therapy against death receptor 5. Int J Radiat Oncol Biol Phys 71:507-516. doi: 10.1016/j.ijrobp.2008.02.005
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , pp. 507-516
    • Fiveash, J.B.1    Gillespie, G.Y.2    Oliver, P.G.3    Zhou, T.4    Belenky, M.L.5    Buchsbaum, D.J.6
  • 26
    • 33749002876 scopus 로고    scopus 로고
    • Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function
    • doi:10.1158/0008-5472.CAN-05-4364
    • Li Y, Wang H, Wang Z, Makhija S, Buchsbaum D, LoBuglio A, Kimberly R, Zhou T (2006) Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function. Cancer Res 66:8520-8528. doi:10.1158/0008-5472.CAN-05-4364
    • (2006) Cancer Res , vol.66 , pp. 8520-8528
    • Li, Y.1    Wang, H.2    Wang, Z.3    Makhija, S.4    Buchsbaum, D.5    Lobuglio, A.6    Kimberly, R.7    Zhou, T.8
  • 27
    • 56349124589 scopus 로고    scopus 로고
    • Identification of an antiapoptotic protein complex at death receptors
    • doi:10.1038/cdd.2008.124
    • Sun M, Song L, Li Y, Zhou T, Jope RS (2008) Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ 15(12):1887-1900. doi:10.1038/cdd.2008.124
    • (2008) Cell Death Differ , vol.15 , Issue.12 , pp. 1887-1900
    • Sun, M.1    Song, L.2    Li, Y.3    Zhou, T.4    Jope, R.S.5
  • 28
    • 54249116378 scopus 로고    scopus 로고
    • Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging
    • doi:10.1158/0008-5472.CAN-08-1771
    • Kim H, Morgan DE, Buchsbaum DJ, Zeng H, Grizzle WE, Warram JM, Stockard CR, McNally LR, Long JW, Sellers JC, Forero A, Zinn KR (2008) Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res 68:8369-8376. doi:10.1158/0008-5472.CAN-08-1771
    • (2008) Cancer Res , vol.68 , pp. 8369-8376
    • Kim, H.1    Morgan, D.E.2    Buchsbaum, D.J.3    Zeng, H.4    Grizzle, W.E.5    Warram, J.M.6    Stockard, C.R.7    McNally, L.R.8    Long, J.W.9    Sellers, J.C.10    Forero, A.11    Zinn, K.R.12
  • 32
    • 79952264098 scopus 로고    scopus 로고
    • New strategies in HER2-over-expressing breast cancer: Many combinations of targeted drugs available
    • doi:10.1158/1078-0432. CCR-09-1947
    • Abramson V, Arteaga CL (2011) New strategies in HER2-over-expressing breast cancer: many combinations of targeted drugs available. Clin Cancer Res 17(5):952-958. doi:10.1158/1078-0432. CCR-09-1947
    • (2011) Clin Cancer Res , vol.17 , Issue.5 , pp. 952-958
    • Abramson, V.1    Arteaga, C.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.